AstraZeneca and its biologics research arm MedImmune have signed a five-year strategic research collaboration with Ethris, an mRNA-based therapeutics company specialising in pulmonary disease.
The Food and Drug Administration (FDA) last week granted the first approval for UK pharma major AstraZeneca’s Datroway ...
Moderna is already riding high on the strength of its mRNA-based COVID-19 vaccine, but the broader potential of its technology has been shown in a new AstraZeneca-partnered candidate for heart ...
Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA ...
As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...
The mRNA jabs, such as Pfizer and Moderna, have also been linked to increases in heart problems. Many countries across Europe halted the AstraZeneca rollout in 2020 after noticing a rise in ...
Merck desperately needs Moderna's mRNA-based Personal Cancer Vaccines ... including significant investments from AstraZeneca and Merck. Although their vaccine candidates remained in early ...
Dame Kate Bingham was commissioned by the previous government to help the UK secure vaccines during the pandemic.
The Government anticipated a £1.7 billion bill for injuries caused by the coronavirus vaccine, the Covid Inquiry has heard.
On Monday, AstraZeneca plc (NASDAQ ... Under the terms of the agree China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the ...
The number of suspected cases of this neurological condition reported from the region has crossed 101. Why is it happening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback